Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data

Why did OPEC+ agree to boost oil production? How will Musk's new America Party impact politics? What caused surge in VC exits this quarter? Why is Texas flood death toll rising rapidly? How will AI affect white-collar jobs according to Ford? What explains retail investors' record stock trading? Why did Berkshire Hathaway stock lag recently?

Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data

benzinga.com/markets/equities/25/07/46258444/cognition-therapeutics-shares-jump-12-after-hours-following-encouraging-phase-2-alzheimers-trial

Cognition Therapeutics Inc (NASDAQ:CGTX) rose 12.10% to $0.45 during after hours on Thursday, following a surge of 20.82% gain during regular hours.
What Happened: The hike in Cognition Therapeutics’ stock price is attributed to the promising results from its Alzheimer’s drug,…

This story appeared on benzinga.com, 2025-07-04 07:32:45.